Respiratory distress and intracranial (in particular, intraventricular) haemorrhage remain among the most important causes of death in the premature infant. The possible role of deficiencies of platelets or coagulation factors in initiating or exacerbating intraventricular haemorrhage is uncertain. Grontoft (1953) felt that because bleeding into the ventricles rarely occurred in association with bleeding at any extracranial site, intraventricular haemorrhage (IVH) was not a symptom of a haemorrhagic diathesis. This view has also been unquestioningly adopted by more recent authors (Harrison, Heese, and Klein, 1968) . In the past few years there has been further speculation about haemostasis in infants with the respiratory distress syndrome (RDS) (Markarian et al., 1967) and in infants with intracranial haemorrhage (Gray, Ackerman, and Fraser, 1968 any evidence of a systemic haemostatic abnormality in infants with the respiratory distress syndrome.
Patients and Methods
The 48 infants in the study were admitted to the Neonatal Ward at Hammersmith Hospital during the period 1969-70. All were 36 weeks of gestation or less as judged by external characteristics, neurological assessment, and mothers' dates; all were therefore potentially at risk from intraventricular haemorrhage. Umbilical arterial catheterization had been performed on all the infants because apnoeic attacks or respiratory distress (the presence of at least two of the following at 4 hours of age: respiratory rate over 60 per minute, sternal recession, or expiratory grunt) necessitated monitoring of the blood gases and pH. 46 infants fulfilled these criteria for the presence of respiratory distress; in 2 infants both of whom weighed less than 1500 g and were of 28 weeks' and 30 weeks' gestation, the indication for catheterization was the presence of recurrent apnoeic attacks which started before the age of 6 hours. Infants born at Hammersmith Hospital were not given vitamin K1: those admitted from other units had usually been given 1 mg K1 i.m. at birth. All the infants were fed with full strength milk feeds (breast milk where possible).
Blood for coagulation studies and platelet counts was taken at the time of insertion of the catheters. Catheters were inserted during the first 24 hours of life, except in 564 2 infants where they were inserted during the second 24 hours. Before any follow-up samples were taken, the catheters were flushed with normal saline. Samples were taken into a 1 in 10 dilution of 3.2% Na citrate with the addition of 1/10th volume of 10% E-amino caproic acid to those samples intended for estimation of plasma fibrinogen and fibrin degradation products.
Methods have been described in detail elsewhere (Chessells, 1971) . The following estimations were performed where possible: platelet count, plasma fibrinogen, Thrombotest, thromboplastin generation screening test (TGST), thrombin time. The Thrombotest was used as a screening test for deficiency of the vitamin K dependent coagulation factors, and the TGST as a screening test for deficiencies of the intrinsic coagulation system. Results of the thrombin time were expressed as a ratio patient/adult normal; the ratio in the normal newbom infant ranges from 1 to 2. Fibrin degradation products (FDP) were measured on thrombin-treated plasma by the method of Merskey, Lalezari, and Johnson (1969) .
Permission for a full necropsy was obtained on all the infants in the study who died. The brain in each case was examined after fixation in formalin for at least one week. In addition to routine material stained with haematoxylin and eosin, sections of the tissues were stained with phosphotungstic acid haematoxylin and reviewed for the presence of fibrin thrombi.
Illustrative Case Histories
The two infants from the series whose case histories are here reported both died within the first 24 hours of life with intraventricular haemorrhage at necropsy. Some infants from each group had laboratory evidence of marked haemostatic abnormality as shown by one or more of the following: platelet count less than 100 x 103/mm3, plasma fibrinogen less than 100 mg/100 ml, TGST 30 seconds or more, Thrombotest less than 10%, or FDP in diluted serum. The number of infants in each group in whom such abnormalities were found is shown in Table II , and detailed results of laboratory studies in all the 16 infants with abnormal laboratory findings are shown in Table III .
Infants from Groups I and II were found to have isolated abnormalities including prolonged TGST (Cases 1 and 2) and circulating FDP (Cases 3 and 4); in one infant (Case 5) these abnormalities were combined. One infant had a low platelet count (Case 6) but neither he nor any other infant from Groups I and II had a bleeding tendency.
Significantly more frequent, and in some cases multiple, abnormalities were found in infants with intracranial haemorrhage (Group III) (see Table II ). There was no obvious difference between the infants with IVH and those with subarachnoid haemorrhage apart from one infant, Case 14, who had thrombcytopenia and a bleeding tendency in life and massive subarachnoid haemorrhage at Infants without intracranial haemorrhage (Group II, Table IV ). It can be seen from Table IV that 6 of the 9 infants in this group had HMD, one of the other 3 infants had pulmonary fibroplasia probably secondary to HMD, and the remaining 2 (both under 1000 g birthweight) had pneumonia.
Infants with intracranial haemorrhage (Group III, Table V ). These cases may be subdivided into those with IVH with or without spread to the subarachnoid space through the foramina of the fourth ventricle (13 infants) and those with primary subarachnoid haemorrhage not originating in an IVH (4 cases). One infant, Case 13, had IVH and a separate subarachnoid haemorrhage. 11 of the 17 infants had HMD at necropsy. Other pathology seen included pneumonia and pulmonary haemorrhage.
Incidence of fibrin thrombi at necropsy (Tables IV  and V) . Fibrin thrombi were seen in the sinusoids of liver and/or adrenals of 4 of the 9 infants without intracranial haemorrhage; all 4 were infants with HMD. Fibrin thrombi were seen also in the liver and/or adrenals of 13 of the 17 infants with intra-consist largely of fibrin. Masses of fibrin seen in cranial haemorrhage including all 5 of those with a the airways were also related to focal haemorrhage. primary subarachnoid haemorrhage. The 17 in-Mixed antemortem thrombi in small arteries or fants in whom fibrin thrombi were seen at necropsy veins were seen in 8 cases; 6 of them had additional included 11 of 12 with laboratory abnormalities in fibrin thrombi in hepatic or adrenal sinusoids. life, and 6 in whom no laboratory defect had been Sites of mixed thrombi were: lung, myocardium, demonstrated. The incidence of fibrin thrombi thyroid, placenta, and umbilical cord, twice each, was similar in those infants who had hyaline and liver, tracheal submucosa. salivary gland, and membranes only (4 out of 7) to that in the infants thymus on one occasion each. with intracranial haemorrhage only (5 out of 7). Thrombi were seen in 8 out of 10 infants with Discussion both conditions. Previous investigations. Previous investigaIn general there was little evidence of fibrin tions of haemostasis in infants with respiratory within the lungs. Hyaline membranes usually distress have pursued two main lines of inquiry; stained poorly for fibrin except in relation to areas the search for local factors influencing fibrinolysis of haemorrhage where the membranes appeared to in the lungs of affected infants, and the study of Ambrus, Weintraub, and Ambrus (1966) and by Lieberman (1969) . In 1961 Wade-Evans reported finding a high incidence of hepatic thrombi in infants with fatal HMD; this report was followed by speculation that RDS may be regularly accompanied by consumption of coagulation factors and platelets (Stark, Abramson, and Erkan, 1968) . Hathaway, Mull, and Pechet (1969) found evidence that disseminated intravascular coagulation (DIC) occurred in some infants with RDS but pointed out that this finding did not necessarily mean that the haemorrhages occurring in such infants were due to DIC. Since respiratory distress is frequently accompanied by IVH it is important to clarify the role of haemostatic failure in causing this form of bleeding.
There are two theoretical ways in which haemostatic defects might cause or exacerbate intraventricular haemorrhage. First, the combination of hepatic immaturity and anoxia in a sick premature infant could theoretically result in impaired synthesis of coagulation factors, manifesting itself as an abnormality of the Thrombotest or TGST. Secondly, haemostatic failure might occur as a consequence of DIC. If DIC had occurred the laboratory findings might include thrombocytopenia, abnormalities of the intrinsic coagulation system (reflected as a prolongation of the TGST), low plasma fibrinogen and circulating FDP. Present laboratory findings. Our investigations of infants with respiratory distress revealed abnormal laboratory findings in one-third of infants; these abnormalities were more common in infants with intracranial haemorrhage at necropsy than in infants surviving or in those dying with no evidence of intracranial haemorrhage. No uniform pattern of laboratory abnormalities was detected but two main patterns emerge.
First, the complex abnormalities found in Cases 5, 8, 13, and 14 are suggestive of a diagnosis of DIC. A prolongation of the TGST was the main abnormal finding in another group of infants (Cases 1, 2, 7, and 9). As individual coagulation factors were not assayed it was not possible to say if this abnormality was due to defective hepatic synthesis of V, IX, and X or the result of utilization of factors V and VIII; the absence of marked depression of the Thrombotest in Cases 1, 2, and 9 and the demonstration of fibrin thrombi in those patients who died (Cases 7 and 9) might indicate that the abnormality was due to utilization of coagulation factors.
Secondly, in 3 infants (Cases 10, 11, and 15) the main abnormal finding was a marked reduction of the Thrombotest percentage though in 2 of the infants (Cases 11 and 15) FDP were also detected.
In two-thirds of the infants in the study, including half of those with IVH at necropsy, there were no clearly abnormal laboratory findings.
Discussion of necropsy findings. The finding of fibrin thrombi in the organs of many of the infants at necropsy is in keeping with the earlier reports of Wade-Evans and requires further discussion. In the present study there was an apparently poor correlation between the laboratory evidence of DIC and the histological findings.
It may be that in some of these infants DIC was a preterminal event and was not suspected in life because no sample for coagulation studies was taken just before death. Alternatively the fibrin deposition may not have been sufficiently extensive to result in depletion of platelets and coagulation factors. We have pointed out previously both the technical difficulties of identifying thrombi in necropsy specimens and the discrepancies between the extent of fibrin shown histologically and the extent of abnormal laboratory findings (Chessells and Wigglesworth, 1971a) .
Implications of present findings; significance of DIC. In the present study haemostatic abnormalities were common in premature infants with respiratory distress; the most common pattern of abnormalities was consistent with a diagnosis of disseminated intravascular coagulation. We feel, however, that this is no reason to assume that intraventricular haemorrhage, when it occurs in such infants, does so as a result of haemostatic failure. A number of infants in the study, Case 24 is a good example, showed neither laboratory nor histological evidence of haemostatic failure; if deficiency of coagulation factors plays a role in causing intraventricular haemorrhage, it is clearly not the only cause of bleeding. Moreover, all the infants with IVH had a normal platelet count; bleeding in the newborn infant with DIC is, in our experience, associated with thrombocytopenia. Case 14, the only infant in the study with a bleeding diathesis, had a platelet count of only 30 x 103/ mm3, and at necropsy, despite her size and immaturity, had not IVH but a massive subarachnoid haemorrhage. By contrast, Case 13, with a normal platelet count despite a low level of plasma fibrinogen and disturbance of the intrinsic coagulation system and FDP in high titre, showed no bleeding at any extracranial site at necropsy.
We think it probable that the apnoeic attacks and hypothermia from which all premature infants with respiratory distress are at risk and which are especially common in infants with IVH (Ross and Dimmette, 1965) may in themselves result in pathological activation of coagulation, thus causing abnormalities of haemostasis and leading to the finding of fibrin thrombi at necropsy. We have shown that such a train of events may occur in severe birth asphyxia (Chessells and Wigglesworth, 1971b (Aballi, 1965) ; the sick infant who has respiratory distress and apnoea may be unable to do so. Thus it is possible that the low Thrombotest levels, like other abnormalities, may be the result rather than the cause of haemorrhage.
Until it is possible to time the actual onset of IVH and relate it to the alterations of levels of coagulation factors in premature infants, all such considerations must remain purely speculative.
Therapeutic implications. If haemostatic failure is the consequence rather than the cause of IVH in premature infants, is any measure to influence the abnormal laboratory findings likely to be of value? It is, perhaps, conceivable that correction of abnormal laboratory findings might prevent further extension of any haemorrhage present.
Effective correction of laboratory abnormalities depends on the cause of these abnormalities. If primary deficiency of coagulation factors, in particular vitamin K dependent factors, is present, vitamin K is unlikely to be effective for reasons already discussed. The alternative therapy would be the use of fresh frozen plasma; since evidence of a primary deficiency is uncommon this form of therapy would rarely appear indicated. If deficiency of coagulation factors is secondary to DIC, neither vitamin K nor plasma are likely to be effective. One must bear in mind that many such episodes are not continuous and recovery may be spontaneous. Any form of treatment in such a situation may be drastic; the use of heparin in a sick infant with intracranial bleeding can hardly be advocated. The alternative of exchange transfusion with fresh heparinized blood could be indicated only if there was very strong evidence of continued bleeding (e.g. in Case 14).
We feel that since haemostatic failure is probably a secondary event in these infants, it is more important to avoid those factors that may initiate haemostatic failure by avoidance of hypothermia, prompt resuscitation of apnoeic attacks, and correction of acidosis. We would make a plea for further investigation into the problem of timing the onset of intracranial haemorrhage of all types.
